{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T23:24:49Z","timestamp":1744241089288},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/maj.0b013e3182267a7b","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T08:55:09Z","timestamp":1312880109000},"page":"254-256","source":"Crossref","is-referenced-by-count":3,"title":["Intracardiac Thrombosis and Acute Myocardial Infarction as Initial Presentation of Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"342","author":[{"given":"Ajay K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Wajid","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Kevin","family":"Heist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0015","first-page":"454","article-title":"Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome","volume":"35","author":"Cianciulli","year":"2008","journal-title":"Tex Heart Inst J"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0020","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jtcvs.2005.05.054","article-title":"Antiphospholipid syndrome and right atrial mass","volume":"130","author":"Basso","year":"2005","journal-title":"J Thorac Cardiovascular Surg"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome","volume":"79","author":"Amengual","year":"1998","journal-title":"J Thromb Hemost"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1191\/0961203303lu339oa","article-title":"evaluation of clinical and laboratory features of APS. A retrospective study of 637 patients","volume":"12","author":"Soletsz","year":"2003","journal-title":"Lupus"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0035","first-page":"1103","article-title":"Myocardial infarction and antiphospholipid antibodies in SLE and related disorder","volume":"73","author":"Asherson","year":"1989","journal-title":"Q J Med"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1742-1241.2006.01245.x","article-title":"Myocardial infarction in young patients without coronary atherosclerosis. Assume primary antiphospholipid syndrome until proven otherwise","volume":"61","author":"Davies","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/096120339800700229","article-title":"Antiphospholipid antibodies and myocardial infarction","volume":"7","author":"Vaarala","year":"1998","journal-title":"Lupus"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000177119","article-title":"Successful treatment of acute MI by thrombolytic therapy in a patient with antiphospholipid syndrome","volume":"87","author":"Ho","year":"1996","journal-title":"Cardiology"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0055","first-page":"194","article-title":"Primary stenting in a patient with acute MI and primary APS","volume":"14","author":"Ozer","year":"2002","journal-title":"J InvasCardiol"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0060","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3182267a7b_bb0065","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915311927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915311927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T22:48:15Z","timestamp":1560466095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915311927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0002962915311927"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3182267a7b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}